Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Activator of 90 kDa heat shock protein ATPase homolog 1 (AHSA1) is a co-chaperone protein that binds and stimulates the ATPase activity of Hsp90, a vital molecular chaperone involved in protein folding, maturation, and trafficking[1][4][5]. AHSA1 modulates conformational dynamics at the dimer interface of Hsp90, impacting the “dwell time” of client proteins and regulating critical cellular functions, including kinase activation, signal transduction, and protein quality control[1][4][5][7]. Dysregulation or altered expression of AHSA1 is associated with cancer progression, neurodegenerative diseases, and other conditions hallmarked by aberrant protein folding[3][4]. While no drugs directly target AHSA1 yet, it is considered a promising therapeutic target due to its regulatory role in Hsp90-dependent processes[1][4].
Small molecules or biologics that inhibit AHSA1 would reduce Hsp90 ATPase activation, impairing chaperone function and destabilizing oncogenic or misfolded proteins\nAntisense or RNAi knockdown reduces protein folding and trafficking of mutant client proteins (e.g., CFTR, tau)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Activator of 90 kDa heat shock protein ATPase homolog 1 (AHSA1).